Nuvo's INVU™ Excels in Remote Pregnancy Care for Gestational Diabetes
Nuvo
—
February 1, 2025
A landmark study in the International Journal of Gynecology & Obstetrics confirms NUVO's INVU™ as essential for maternal-fetal remote care. Conducted at Sheba Medical Center, it achieved a 97.4% success rate, cutting visit times by two-thirds and improving glucose monitoring.
The study, conducted at Sheba Beyond, Sheba Medical Center, Tel Hashomer virtual hospital, showcased the successful implementation of INVU™ alongside other digital health technologies in a comprehensive remote monitoring solution for gestational diabetes.
Technology Integration Partners:
- NUVO (INVU™): Provided remote fetal monitoring capabilities enabling real-time professional interpretation of non-stress tests
- PulseNmore: Supplied remote ultrasound technology for measuring amniotic fluid maximal vertical pocket, enabling complete modified biophysical profile assessment from home
- Healthy.io: Delivered digital urinalysis technology for remote monitoring of protein levels and maternal health indicators
- Datos Health: Provided the digital platform for monitoring vital signs and glycemic control.
The integrated solution enabled:
- Remote non-stress testing with real-time professional interpretation
- Home-based fetal surveillance
- Continuous maternal health monitoring
- Digital glucose tracking and diabetes management
- Remote urinalysis and vital signs monitoring
- Comprehensive virtual care visits
- Integration with electronic health records
The study validated INVU's effectiveness in managing various high-risk pregnancy conditions, including:
- Gestational diabetes (both A1GD and A2GD)
- Pregnancies requiring antepartum fetal surveillance
- Cases needing regular non-stress tests
- Conditions requiring a modified biophysical profile
- High-risk pregnancies at or beyond 32 weeks gestation
The research team achieved a remarkable 97.4% success rate in completing remote maternal-fetal assessments, with visit durations reduced by nearly two-thirds compared to in-clinic appointments. Clinical outcomes were notably positive, with high patient satisfaction scores (6.6 out of 7) and improved adherence to glucose monitoring protocols during the hybrid care. The research demonstrated that INVU can be effectively integrated into a broader remote care ecosystem, providing comprehensive care for maternal hypertensive disorders, fetal growth monitoring, and high-risk pregnancy surveillance.
This successful integration demonstrates INVU's pivotal role in the future of maternal-fetal medicine, particularly in managing complex pregnancies requiring regular monitoring and assessment. Healthcare providers looking to implement comprehensive remote care programs for maternal-fetal care can benefit from INVU's proven platform.